New York Attorney General Settlement With Endo Health Solutions Inc. and Endo Pharmaceuticals Inc.
This document released on March 3, 2016, by the New York Attorney General's Office is a settlement with Endo Pharmaceuticals regarding Endo's marketing practices for Opana ER, a brand name opioid pain reliever with abuse deterrent properties. In entering the settlement, Endo admitted no wrongdoing, but did agree to make the changes required by the state . . .

